<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="164616">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01658397</url>
  </required_header>
  <id_info>
    <org_study_id>2010P001066</org_study_id>
    <nct_id>NCT01658397</nct_id>
  </id_info>
  <brief_title>The Effect of Calorie Deprivation on Adipose Tissue Distribution</brief_title>
  <official_title>The Effect of Calorie Deprivation on Adipose Tissue Distribution</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, we will be studying the effects of acute calorie deprivation (a 10-day fast)
      on bone marrow fat, other fat stores and bone parameters.  We will be measuring changes in
      bone marrow fat using magnetic resonance spectroscopy and will use MRI to measure
      subcutaneous and visceral fat depots.  Our hypothesis is that levels of bone marrow fat will
      increase after an acute fast.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>Change in Bone Marrow Adiposity over 10 day fasting period</measure>
    <time_frame>Baseline, After 10 day fasting period</time_frame>
    <safety_issue>No</safety_issue>
    <description>Bone marrow adiposity will be measured before and after the 10 day fast using magnetic resonance spectroscopy.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Fasting</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ten day fast</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Fasting</intervention_name>
    <description>Ten day fast</description>
    <arm_group_label>Fasting</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women, ages 21-45 years

          -  101-130% of ideal body weight as defined by the 1983 Metropolitan Life Insurance
             Height and Weight Tables

          -  Normal thyroid function

          -  Regular menses (women)

          -  Normal liver transaminases

        Exclusion Criteria:

          -  Any disease known to affect bone metabolism, including untreated thyroid dysfunction,
             Cushing's syndrome, or renal failure

          -  Any medication known to affect bone metabolism -- including systemic steroids or
             immunosuppressants --  within three months of the study, excluding estrogen and
             progestins. Patients receiving depot medroxyprogesterone (Depo-Provera) will be
             excluded from participating for six months after their last injections.
             Bisphosphonates must have been discontinued for at least one year before
             participation

          -  Serum potassium &lt;3.0 meq/L

          -  Pregnant and/or breastfeeding (women)

          -  Diabetes mellitus

          -  Active substance abuse, including alcohol

          -  Contraindications to MRI: cardiac pacemaker, metal implants, claustrophobia
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pouneh K Fazeli, MD</last_name>
    <phone>617-726-3870</phone>
    <email>pkfazeli@partners.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pouneh K Fazeli, MD</last_name>
      <phone>617-726-3870</phone>
      <email>pkfazeli@partners.org</email>
    </contact>
    <investigator>
      <last_name>Pouneh K Fazeli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 6, 2014</lastchanged_date>
  <firstreceived_date>August 1, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Pouneh K. Fazeli, MD</investigator_full_name>
    <investigator_title>Instructor in Medicine</investigator_title>
  </responsible_party>
  <keyword>Healthy subjects</keyword>
  <keyword>Fasting</keyword>
  <keyword>Weight loss</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
